Logos Global Management LP Apellis Pharmaceuticals, Inc. Call Options Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.07 - $59.71 $76.1 Million - $119 Million
2,000,000 New
2,000,000 $76.7 Million
Q4 2023

Feb 14, 2024
BUY
$37.14 - $64.82 $13 Million - $22.7 Million
350,000 Added 53.85%
1,000,000 $59.9 Million
Q3 2023

Nov 14, 2023
BUY
$23.65 - $89.22 $15.4 Million - $58 Million
650,000 New
650,000 $24.7 Million

Others Institutions Holding APLS

# of Institutions
303
Shares Held
112M
Call Options Held
5.03M
Put Options Held
703K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.1B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email